» Articles » PMID: 39595895

Prion-like Spreading of Disease in TDP-43 Proteinopathies

Overview
Journal Brain Sci
Publisher MDPI
Date 2024 Nov 27
PMID 39595895
Authors
Affiliations
Soon will be listed here.
Abstract

TDP-43 is a ubiquitous nuclear protein that plays a central role in neurodegenerative disorders collectively known as TDP-43 proteinopathies. Under physiological conditions, TDP-43 is primarily localized to the nucleus, but in its pathological form it aggregates in the cytoplasm, contributing to neuronal death. Given its association with numerous diseases, particularly ALS and FTLD, the mechanisms underlying TDP-43 aggregation and its impact on neuronal function have been extensively investigated. However, little is still known about the spreading of this pathology from cell to cell. Recent research has unveiled the possibility that TDP-43 may possess prion-like properties. Specifically, misfolded TDP-43 aggregates can act as templates inducing conformational changes in native TDP-43 molecules and propagating the misfolded state across neural networks. This review summarizes the mounting and most recent evidence from in vitro and in vivo studies supporting the prion-like hypothesis and its underlying mechanisms. The prion-like behavior of TDP-43 has significant implications for diagnostics and therapeutics. Importantly, emerging strategies such as small molecule inhibitors, immunotherapies, and gene therapies targeting TDP-43 propagation offer promising avenues for developing effective treatments. By elucidating the mechanisms of TDP-43 spreading, we therefore aim to pave the way for novel therapies for TDP-43-related neurodegenerative diseases.

Citing Articles

The Neonatal Microbiome: Implications for Amyotrophic Lateral Sclerosis and Other Neurodegenerations.

Eisen A, Kiernan M Brain Sci. 2025; 15(2).

PMID: 40002527 PMC: 11852589. DOI: 10.3390/brainsci15020195.

References
1.
Furukawa Y, Kaneko K, Watanabe S, Yamanaka K, Nukina N . A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions. J Biol Chem. 2011; 286(21):18664-72. PMC: 3099683. DOI: 10.1074/jbc.M111.231209. View

2.
Sjekloca L, Buratti E . tRNA binds TDP-43 RNA recognition motifs and ligand of Ate1 protein LIAT1. MicroPubl Biol. 2024; 2024. PMC: 11287377. DOI: 10.17912/micropub.biology.001224. View

3.
Porta S, Xu Y, Lehr T, Zhang B, Meymand E, Olufemi M . Distinct brain-derived TDP-43 strains from FTLD-TDP subtypes induce diverse morphological TDP-43 aggregates and spreading patterns in vitro and in vivo. Neuropathol Appl Neurobiol. 2021; 47(7):1033-1049. PMC: 8578586. DOI: 10.1111/nan.12732. View

4.
Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y . Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol. 2008; 64(1):60-70. PMC: 2674108. DOI: 10.1002/ana.21425. View

5.
Luthi-Carter R, Cappelli S, Le Roux-Bourdieu M, Tentillier N, Quinn J, Petrozziello T . Location and function of TDP-43 in platelets, alterations in neurodegenerative diseases and arising considerations for current plasma biobank protocols. Sci Rep. 2024; 14(1):21837. PMC: 11410945. DOI: 10.1038/s41598-024-70822-8. View